Umbilical Cord Blood Transplant for Hematological Malignancies

NCT00891592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

CML
AML
MDS
ALL
NHL
Multiple Myeloma
Hodgkin's Disease

Interventions

BIOLOGICAL: Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
OTHER: Observation Arm

Sponsor

University of Pennsylvania